168 related articles for article (PubMed ID: 19816777)
1. Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients.
Xie F; Li K; Ouyang X
Clin Exp Metastasis; 2009; 26(8):1025-32. PubMed ID: 19816777
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.
Yuen HF; Chan YP; Wong ML; Kwok WK; Chan KK; Lee PY; Srivastava G; Law SY; Wong YC; Wang X; Chan KW
J Clin Pathol; 2007 May; 60(5):510-4. PubMed ID: 16822877
[TBL] [Abstract][Full Text] [Related]
4. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakamoto A; Owaki T; Aikou T
J Exp Clin Cancer Res; 2009 Dec; 28(1):158. PubMed ID: 20025748
[TBL] [Abstract][Full Text] [Related]
5. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
[TBL] [Abstract][Full Text] [Related]
6. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
7. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma.
Ren P; Yu ZT; Xiu L; Wang M; Liu HM
World J Gastroenterol; 2013 Apr; 19(15):2412-8. PubMed ID: 23613637
[TBL] [Abstract][Full Text] [Related]
10. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma.
Chen GQ; Tian H; Yue WM; Li L; Li SH; Qi L; Gao C; Si LB; Lu M
Med Oncol; 2014 Dec; 31(12):376. PubMed ID: 25416054
[TBL] [Abstract][Full Text] [Related]
11. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
[TBL] [Abstract][Full Text] [Related]
13. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
15. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
17. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
19. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma.
Hou X; Liang RB; Wei JC; Xu Y; Fu JH; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
Oncotarget; 2016 May; 7(21):31088-96. PubMed ID: 27145270
[TBL] [Abstract][Full Text] [Related]
20. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
